Animal drug compounding is a mixing or of drugs prepared by approved pharmacist to fulfill the particular patient’s requirement. These drugs are made by combination and alteration of necessary active pharmaceutical ingredients as per prescription and requirement. Drugs compounding also includes preparing a suspension from crushed tablets and adding flavors to it. Drug compounding allows only the use of FDA approved drugs, not the raw pharmaceutical ingredients. Drug compounding also allows veterinarians to treat animals with available human medical drugs. In most rare cases, when there are no approved drugs available for the treatment of a particular condition, the animal drug can be compounded from bulk drug substances which can be an appropriate treatment option. Despite several advantages of compounded drugs, these drugs are not intended to use for food-producing animals such as cattle, sheep, swine, goats, chickens, turkeys and non-ornamental fish.
The growth of veterinary drug compounding market is mainly driven by the increasing number of pets and growing adoption of compounded drugs to increase animal compliance with flavoring alternatives and route of administration. Currently, many drugs are approved for animal treatment. However, these are still many different species with different rare diseases conditions for which there are no FDA-approved drugs available. To overcome this issue many approved human drugs are used for the treatment of the animal with the help of drug compounding, for example, several approved chemotherapeutic drugs are used to treat cancer in dogs and cats. Moreover, the emergence of veterinary specialties such as oncology, cardiology, and neurology, and the growth of veterinary referral centers is expected to drive the need for compounded medications. The growing trend of pet adoption is expected to boost the veterinary drug compounding market. In Japan, the companion dog population has increased to approximately 12.5 million and cats have increased up to 11.6 million. Similarly, in Australia, the companion dog population has increased to 3.75 million, cats up to 2.43 million, and other animals such as birds, rodents, and fish has increased to 32.9 million other animals.
A Sample of this Report is Available Upon Request @ http://www.persistencemarketresearch.com/samples/12871
Based on geographic region, veterinary drugs compounding market is segmented into five key regions: North America, Latin America, Europe, Asia-Pacific and Middle East & Africa. North America holds the largest revenue share in the veterinary drugs compounding market followed by Europe owing to well-established animal healthcare market and growing number of veterinary practitioners etc. Asia-Pacific is expected to grow at the fastest CAGR owing to the growing trend of pet animals especially in China and India. Moreover, increasing the focus of pet owners towards the animal health and safety have boosted the growth for veterinary drugs compounding market.
Some of the key players in veterinary drug compounding market are Sanofi-Aventis, Novartis, Fagron, Pfizer Inc., Essential Pharmacy Compounding, Triangle Compounding Pharmacies, and Lorraine’s Pharmacy among others.
To View TOC of this Report is Available Upon Request @ http://www.persistencemarketresearch.com/toc/12871
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, product types, end users, and distribution channel.
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Persistence Market Research
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353